Senior European role for Aurélie-Anne Chausse at Kyowa Kirin

14 October 2025

Aurélie-Anne Chausse (pictured above) has joined the Kyowa Kirin International (KKI) unit of Japanese drugmaker Kyowa Kirin (TYO: 4151) in the France and Benelux-focused role of general manager, central cluster.

Ms Chausse brings with her more than 22 years’ experience in the pharmaceutical industry, all spent at French pharma major Sanofi (Euronext: SAN), where she most recently served as vice president, global marketing, multiple myeloma. 

Over the course of her career, she has held a wide range of leadership positions at both country and global level, including marketing, strategic project director, franchise director, chief of staff and business unit director.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight



More Features in Pharmaceutical